MFN2 suppresses clear cell renal cell carcinoma progression by modulating mitochondria‐dependent dephosphorylation of EGFR.

MLA

Luo, Li, et al. “MFN2 Suppresses Clear Cell Renal Cell Carcinoma Progression by Modulating Mitochondria‐dependent Dephosphorylation of EGFR.” Cancer Communications, vol. 43, no. 7, July 2023, pp. 808–33. EBSCOhost, https://doi.org/10.1002/cac2.12428.

APA

Luo, L., Wei, D., Pan, Y., Wang, Q., Feng, J., Yu, B., Kang, T., Luo, J., Yang, J., & Gao, S. (2023). MFN2 suppresses clear cell renal cell carcinoma progression by modulating mitochondria‐dependent dephosphorylation of EGFR. Cancer Communications, 43(7), 808–833. https://doi.org/10.1002/cac2.12428

Chicago

Luo, Li, Denghui Wei, Yihui Pan, Qiu‐Xia Wang, Jian‐Xiong Feng, Bing Yu, Tiebang Kang, Junhang Luo, Jiefeng Yang, and Song Gao. 2023. “MFN2 Suppresses Clear Cell Renal Cell Carcinoma Progression by Modulating Mitochondria‐dependent Dephosphorylation of EGFR.” Cancer Communications 43 (7): 808–33. doi:10.1002/cac2.12428.